Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan

Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan

2020 Journal of Infection and Chemotherapy

Skrzeczek, Aleksandra | Ikeoka, Hidetoshi | Hirotsu, Nobuo | Ansaripour, Amir | Aballéa, Samuel | Onishi, Yoshie | Hill, Mark | Igarashi, Ataru | Volume: , Issue: , Pages: ,

BackgroundBaloxavir marboxil (baloxavir) is a new oral antiviral for influenza types A and B.

https://www.doi.org/10.1016/j.jiac.2020.10.018